CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 92 filers reported holding CYTOKINETICS INC in Q4 2013. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,632,000 | +31.8% | 134,303 | -0.4% | 0.00% | 0.0% |
Q3 2016 | $1,238,000 | +0.8% | 134,826 | +4.2% | 0.00% | 0.0% |
Q2 2016 | $1,228,000 | +36.1% | 129,386 | +1.1% | 0.00% | +100.0% |
Q1 2016 | $902,000 | -32.1% | 127,988 | +0.7% | 0.00% | -50.0% |
Q4 2015 | $1,329,000 | +57.8% | 127,055 | +0.9% | 0.00% | +100.0% |
Q3 2015 | $842,000 | -3.2% | 125,895 | -2.8% | 0.00% | 0.0% |
Q2 2015 | $870,000 | +12.1% | 129,536 | +13.2% | 0.00% | 0.0% |
Q1 2015 | $776,000 | -15.9% | 114,474 | -0.6% | 0.00% | 0.0% |
Q4 2014 | $923,000 | +124.0% | 115,217 | -1.6% | 0.00% | 0.0% |
Q3 2014 | $412,000 | -24.0% | 117,069 | +3.2% | 0.00% | 0.0% |
Q2 2014 | $542,000 | -38.9% | 113,429 | +21.4% | 0.00% | 0.0% |
Q1 2014 | $887,000 | +77.8% | 93,408 | +21.7% | 0.00% | 0.0% |
Q4 2013 | $499,000 | -15.4% | 76,766 | -1.5% | 0.00% | 0.0% |
Q3 2013 | $590,000 | – | 77,970 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |